Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Adipocytokines in Steatotic Liver Surgery/Transplantation.

Jiménez-Castro MB, Casillas-Ramírez A, Negrete-Sánchez E, Avalos-de León CG, Gracia-Sancho J, Peralta C.

Transplantation. 2019 Jan;103(1):71-77. doi: 10.1097/TP.0000000000002098.

PMID:
30586349
2.

The effect of cortisol in rat steatotic and non-steatotic liver transplantation from brain-dead donors.

Jiménez-Castro MB, Negrete-Sánchez E, Casillas-Ramírez A, Gulfo J, Álvarez-Mercado AI, Cornide-Petronio ME, Gracia-Sancho J, Rodés J, Peralta C.

Clin Sci (Lond). 2017 Apr 25;131(8):733-746. doi: 10.1042/CS20160676. Epub 2017 Feb 28.

PMID:
28246131
3.

The Effect of High-Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death.

Cornide-Petronio ME, Negrete-Sánchez E, Mendes-Braz M, Casillas-Ramírez A, Bujaldon E, Meroño N, Martínez-Carreres L, Gracia-Sancho J, Rodés J, Jiménez-Castro MB, Peralta C.

Am J Transplant. 2016 Apr;16(4):1148-59. doi: 10.1111/ajt.13560. Epub 2015 Dec 24.

4.

Is Ischemic Preconditioning a Useful Therapeutic Strategy in Liver Transplantation? Results from the First Pilot Study in Mexico.

Zapata-Chavira HA, Cordero-Pérez P, Casillas-Ramírez A, Escobedo-Villarreal MM, Pérez-Rodríguez E, Torres-González L, Camara-Lemarroy C, Hernández-Guedea MA, Caballero-Mendoza E, Muñoz-Espinosa LE.

Arch Med Res. 2015 May;46(4):296-302. doi: 10.1016/j.arcmed.2015.06.002. Epub 2015 Jun 11.

PMID:
26074359
5.

Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update.

Gracia-Sancho J, Casillas-Ramírez A, Peralta C.

Clin Sci (Lond). 2015 Aug;129(4):345-62. doi: 10.1042/CS20150223. Review.

PMID:
26014222
6.

The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning.

Jiménez-Castro MB, Meroño N, Mendes-Braz M, Gracia-Sancho J, Martínez-Carreres L, Cornide-Petronio ME, Casillas-Ramirez A, Rodés J, Peralta C.

J Hepatol. 2015 Jan;62(1):83-91. doi: 10.1016/j.jhep.2014.07.031. Epub 2014 Aug 8.

PMID:
25111175
7.

Adiponectin and resistin protect steatotic livers undergoing transplantation.

Jiménez-Castro MB, Casillas-Ramírez A, Mendes-Braz M, Massip-Salcedo M, Gracia-Sancho J, Elias-Miró M, Rodés J, Peralta C.

J Hepatol. 2013 Dec;59(6):1208-14. doi: 10.1016/j.jhep.2013.07.015. Epub 2013 Jul 16.

PMID:
23867317
8.

Tauroursodeoxycholic acid affects PPARγ and TLR4 in Steatotic liver transplantation.

Jiménez-Castro MB, Elias-Miro M, Mendes-Braz M, Lemoine A, Rimola A, Rodés J, Casillas-Ramírez A, Peralta C.

Am J Transplant. 2012 Dec;12(12):3257-71. doi: 10.1111/j.1600-6143.2012.04261.x. Epub 2012 Sep 20.

9.

Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.

Elias-Miró M, Massip-Salcedo M, Raila J, Schweigert F, Mendes-Braz M, Ramalho F, Jiménez-Castro MB, Casillas-Ramírez A, Bermudo R, Rimola A, Rodes J, Peralta C.

Liver Transpl. 2012 Oct;18(10):1198-208. doi: 10.1002/lt.23489.

10.

The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury.

Elias-Miró M, Jiménez-Castro MB, Mendes-Braz M, Casillas-Ramírez A, Peralta C.

PPAR Res. 2012;2012:802384. doi: 10.1155/2012/802384. Epub 2012 May 16.

11.

The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.

Mendes-Braz M, Elias-Miró M, Jiménez-Castro MB, Casillas-Ramírez A, Ramalho FS, Peralta C.

J Biomed Biotechnol. 2012;2012:298657. doi: 10.1155/2012/298657. Epub 2012 May 9. Review.

12.

Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation.

Jimenez-Castro MB, Casillas-Ramirez A, Massip-Salcedo M, Elias-Miro M, Serafin A, Rimola A, Rodes J, Peralta C.

Liver Transpl. 2011 Sep;17(9):1099-110. doi: 10.1002/lt.22359.

13.

Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation.

Casillas-Ramírez A, Alfany-Fernández I, Massip-Salcedo M, Juan ME, Planas JM, Serafín A, Pallàs M, Rimola A, Rodés J, Peralta C.

J Pharmacol Exp Ther. 2011 Jul;338(1):143-53. doi: 10.1124/jpet.110.177691. Epub 2011 Apr 12.

PMID:
21487070
14.

Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution.

Zaouali MA, Padrissa-Altés S, Ben Mosbah I, Alfany-Fernandez I, Massip-Salcedo M, Casillas-Ramirez A, Bintanel-Morcillo M, Boillot O, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Liver Transpl. 2010 Sep;16(9):1098-111. doi: 10.1002/lt.22126.

15.

Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Casillas-Ramírez A, Zaouali A, Padrissa-Altés S, Ben Mosbah I, Pertosa A, Alfany-Fernández I, Bintanel-Morcillo M, Xaus C, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Endocrinology. 2009 Jul;150(7):3153-61. doi: 10.1210/en.2008-1458. Epub 2009 Mar 12.

16.

Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.

Alfany-Fernandez I, Casillas-Ramirez A, Bintanel-Morcillo M, Brosnihan KB, Ferrario CM, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C.

Am J Transplant. 2009 Mar;9(3):439-51. doi: 10.1111/j.1600-6143.2008.02521.x. Epub 2008 Feb 3.

17.

Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?

Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

J Pharmacol Exp Ther. 2009 Apr;329(1):130-40. doi: 10.1124/jpet.108.147835. Epub 2008 Dec 30.

PMID:
19116369
18.

Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.

Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

Crit Care Med. 2008 Apr;36(4):1256-66. doi: 10.1097/CCM.0b013e31816a023c.

PMID:
18379253
19.

Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion.

Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, Casillas-Ramirez A, Rodés J, Roselló-Catafau J, Peralta C.

Hepatology. 2008 Feb;47(2):461-72.

PMID:
18098300
20.

Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation.

Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, Peralta C.

Life Sci. 2006 Oct 12;79(20):1881-94. Epub 2006 Jun 20. Review.

PMID:
16828807
21.

[Ischemia-reperfusion syndrome associated with liver transplantation: an update].

Casillas-Ramírez A, Mosbah IB, Franco-Gou R, Rimola A, Roselló-Catafau J, Peralta C.

Gastroenterol Hepatol. 2006 May;29(5):306-13. Review. Spanish.

PMID:
16733038
22.

Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers.

Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, Bartrons R, Ben Mosbah I, Serafin A, Roselló-Catafau J, Peralta C.

Am J Pathol. 2006 May;168(5):1474-85.

23.

Trimetazidine: is it a promising drug for use in steatotic grafts?

Ben Mosbah I, Casillas-Ramírez A, Xaus C, Serafín A, Roselló-Catafau J, Peralta C.

World J Gastroenterol. 2006 Feb 14;12(6):908-14.

24.

How ischaemic preconditioning protects small liver grafts.

Franco-Gou R, Roselló-Catafau J, Casillas-Ramirez A, Massip-Salcedo M, Rimola A, Calvo N, Bartrons R, Peralta C.

J Pathol. 2006 Jan;208(1):62-73.

PMID:
16261637

Supplemental Content

Loading ...
Support Center